AGO2 and non-small cell lung carcinoma: RIP experiment demonstrated that HOXA-AS2 and miR-520a-3p were both enriched in Ago2 pellets compared with control IgG in A549 cells (Figure 4C), suggesting that miR-520a-3p could interact with HOXA-AS2 in NSCLC cells.